Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.18 USD | +0.78% | +4.89% | +5.89% |
Jan. 02 | Ares Capital Prices $1 Billion of 2032 Notes | MT |
Dec. 20 | ADMA Biologics Repays $30 Million of Term Loan Facility | MT |
Capitalization | 14.98B 14.4B 13.6B 12.18B 21.44B 1,291B 23.92B 165B 61.21B 533B 56.17B 55.01B 2,331B | P/E ratio 2024 * |
9.44x | P/E ratio 2025 * | 10.5x |
---|---|---|---|---|---|
Enterprise value | 28.24B 27.16B 25.64B 22.96B 40.44B 2,435B 45.1B 312B 115B 1,004B 106B 104B 4,396B | EV / Sales 2024 * |
9.36x | EV / Sales 2025 * | 9.2x |
Free-Float |
99.18% | Yield 2024 * |
8.28% | Yield 2025 * | 8.3% |
Last Transcript: Ares Capital Corporation
1 day | +0.78% | ||
1 week | +4.89% | ||
Current month | +5.89% | ||
1 month | +8.42% | ||
3 months | +7.07% | ||
6 months | +11.93% | ||
Current year | +5.89% |
Director | Title | Age | Since |
---|---|---|---|
Kipp deVeer
CEO | Chief Executive Officer | 52 | 2014-06-30 |
Kort Schnabel
PSD | President | 48 | 2022-10-19 |
Mitch Goldstein
PSD | President | 58 | 2014-06-30 |
Manager | Title | Age | Since |
---|---|---|---|
Eric Siegel
BRD | Director/Board Member | 67 | 2003-12-31 |
Robert Rosen
BRD | Director/Board Member | 78 | 2003-12-31 |
Ann Bates
BRD | Director/Board Member | 67 | 2009-12-31 |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.78% | +4.89% | +13.85% | +8.78% | 14.98B | ||
+2.92% | +7.43% | +15.41% | +35.56% | 9.63B | ||
-0.43% | +1.80% | +32.76% | +44.03% | 8.73B | ||
+0.16% | +1.33% | +1.77% | -24.00% | 6.65B | ||
+0.45% | +3.82% | +7.95% | +1.27% | 6.23B | ||
-1.36% | +2.62% | +33.95% | +20.47% | 5.29B | ||
+0.06% | +2.30% | +44.74% | +59.18% | 5.12B | ||
+0.37% | +0.04% | -25.63% | +70.96% | 4.63B | ||
-2.05% | 0.00% | -3.73% | -12.68% | 3.52B | ||
+0.09% | +1.72% | -14.29% | -23.32% | 3.53B | ||
Average | +0.10% | +2.38% | +10.68% | +18.03% | 6.83B | |
Weighted average by Cap. | +0.41% | +3.15% | +13.61% | +19.31% |
2024 * | 2025 * | |
---|---|---|
Net sales | 3.02B 2.9B 2.74B 2.45B 4.32B 260B 4.82B 33.27B 12.33B 107B 11.31B 11.08B 470B | 3.13B 3.01B 2.84B 2.54B 4.48B 270B 5B 34.51B 12.79B 111B 11.73B 11.49B 487B |
Net income | 1.54B 1.48B 1.4B 1.25B 2.21B 133B 2.46B 17.01B 6.3B 54.84B 5.78B 5.66B 240B | 1.46B 1.4B 1.32B 1.19B 2.09B 126B 2.33B 16.09B 5.96B 51.88B 5.47B 5.36B 227B |
Net Debt | 13.27B 12.76B 12.04B 10.79B 19B 1,144B 21.18B 146B 54.22B 472B 49.75B 48.73B 2,065B | 13.81B 13.28B 12.54B 11.23B 19.78B 1,191B 22.06B 152B 56.45B 491B 51.8B 50.73B 2,150B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-17 | 23.18 $ | +0.78% | 3,894,855 |
25-01-16 | 23.00 $ | +1.50% | 3,854,192 |
25-01-15 | 22.66 $ | +1.03% | 4,083,452 |
25-01-14 | 22.43 $ | +1.49% | 2,940,377 |
Delayed Quote Nasdaq, January 17, 2025 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- ARCC Stock